Further Characterization of Activin A-induced IgA Response in Murine B Lymphocytes by Lee, Hwa-Joung & Kim, Pyeung-Hyeun
IMMUNE NETWORK http://www.ksimm.or.kr Volume 9 Number 4 August 2009
DOI 10.4110/in.2009.9.4.133
PISSN 1598-2629
133
ORIGINAL ARTICLE
Received on July 29, 2009. Revised on August 11, 2009. Accepted on August 18, 2009.
*Corresponding Author. Tel: 82-33-250-8546; Fax: 82-33-241-4627; E-mail: phkim@kangwon.ac.kr
Keywords: activin A, TGF-β, IgA, mesenteric lymph node, CFSE
Further Characterization of Activin A-induced IgA Response in 
Murine B Lymphocytes
Hwa-Joung Lee
1 and Pyeung-Hyeun Kim
1,2*
1Department of Molecular Bioscience, School of Bioscience and Biotechnology, 
2Medical & Bio-material Research Center, Kangwon 
National University, Chuncheon 200-701, Korea
We have recently shown that activin A, a member of TGF-β 
superfamily, stimulates mouse B cells to express IgA isotype 
but other isotypes. In the present study, we further charac-
terized effects of activin A on B cell growth and IgA 
expression. We found that activin A did not have effect on 
LPS-stimulated cell viability. In parallel, CFSE staining analy-
sis revealed that activin A did not alter cell division. An in-
crease of IgA secretion by activin A was completely abro-
gated by anti-activin A Ab but not by anti-TGFβ1 Ab. In the 
same conditions, no other isotypes are significantly affected 
by each antibody treatment. Finally, activin A, as similar to 
TGF-β1, increased IgA secretion by mesenteric lymph node 
cells. These results suggest that activin A can specifically 
stimulate IgA response, independent of TGF-β  in the gut. 
[Immune Network 2009;9(4):133-137]
INTRODUCTION
IgA  is  the  major  Ig  isotype  in  mucosal  secretions  and  con-
stitutes the great majority of the Ig synthesized in mucosal tis-
sues (1,2). IgA class-switch recombination (CSR) mainly takes 
place in Peyer’s patches (PP) and then, IgA
＋ B cells migrate 
through the lymph and blood circulation and eventually home 
to lamina propria of the intestine (3). TGF-β1 is known to in-
duce IgA and IgG2b CSR in murine B cells (4-9). In addition, 
TGF-β1  inhibits  B  cell  proliferation  and  cell  cycle  pro-
gression in the mid to late G1 phase of the cell cycle (10-12). 
    Activin A, a member of the TGF-β superfamily, is a local 
regulator of cell growth and differentiation (13). Activin A is 
known  to  be  produced  by  Th2  but  not  by  Th1  cells  upon 
activation (14). We have recently shown that activin A stim-
ulates IgA expression in mouse B cells (15). Thus, activin A 
increased the expression of Ig germ-line α transcripts, an in-
dicative  of  IgA  CSR,  via  Smad3  and  Smad4  leading  to  in-
creased  IgA  secretion. 
    Since both activin A and TGF-β1 use the same proteins 
(Smad3 and/or Smad4) in signal transduction and enhances 
IgA response, it was necessary to determine whether the ac-
tivity  of  activin  A  is  related  to  that  of  TGF-β1.  We found 
that  activin  A  little  affected  B  cell  proliferation,  which  was 
contrasted  to  anti-proliferative  activity  of  TGF-β1.  In  addi-
tion, we found that activin A can independently modulate B 
cells  to  express  IgA  and  that  this  may  occur  in  mesenteric 
lymph  nodes  of  the  gut. 
MATERIALS AND METHODS
Animals
BALB/c mice were purchased from Orient. Co. Ltd. (Gyeonggi- 
do, Korea) and maintained in an animal environmental con-
trol  chamber  (Myung  Jin  Inst.  Co.,  Seoul,  Korea).  Animals 
were  fed  Purina  Laboratory  Rodent  Chow  5001  ad  libitum. 
Eight to twelve weeks age of mice were used in this study. 
Animal care was in accordance of with the institutional guide-
lines  set  forth  by  Kangwon  National  University.
B cell preparations and cell culture
The murine B lymphoma cell line, CH12F3-2A was provided 
by Dr. T. Honjo (Osaka University, Japan) (16). These  cells 
were cultured at 37
oC in a humidified atmosphere containing 
5%  CO2 i n  R P M I  1 , 6 4 0  m e d i u m  ( S i g m a )  s u p p l e m e n t e d  w i t h  
10% FBS, 50μM 2-ME, 5 mM HEPES, penicillin (100 U/ml)/ 
streptomycin  (100μg/ml).  Mouse  spleen  B  cell  suspensions 
were prepared as described before (4) and whole mesenteric Characterization of Activin A-induced IgA Response
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Figure 1. Effect of activin A and TGF-β1 on the growth kinetics of 
splenic B cells. Normal spleen B cells (1×10
6) stimulated with LPS 
were cultured in the presence of TGF-β1 (0.2 ng/ml) and activin A
(10 ng/ml). Numbers of viable cells were enumerated by trypan blue 
exclusion. Data are means±SEM (bars) of triplicate culture wells.
Figure 2. Effect of activin A on B cell 
proliferation. CFSE-labeled splenic B cells 
(1×10
6) were cultured as in Fig. 1. After 
48 h, 72 h, and 96 h incubation, B cell 
proliferation was assessed by analyzing the
dilution of CFSE in the same number of 
viable cells.
lymph  node  cells  were  prepared  as  teasing  the  tissues  with 
forceps.
Isotype-specific ELISA
ELISAs were performed as described previously (17). The re-
action  products  were  measured  at  405  nm  with  an  ELISA 
reader  (Molecular  Devices  VERSAMAX  reader,  Molecular 
Devices,  Sunnyvale,  CA,  USA).
CFSE staining and analysis 
Isolated mouse spleen B cells were labeled with a CFSE kit 
(Invitrogen Life Technologies, Carlsbad, CA, USA), according 
to the manufacture’s instruction, and added with LPS, activin 
A (10 ng/ml), and TGF-β1 (0.2 ng/ml). Dilution of CFSE was 
measured by counting 30,000 viable cells with a FACSCalibur 
(BD  Biosciences).
RESULTS AND DISCUSSION
Activin A do not alter the cell proliferation and via-
bility
We have recently shown that activin A selectively stimulates 
IgA expression (15). However, the relationship between ac-
tions of activin A and TGF-β1 in the context of IgA CSR is Characterization of Activin A-induced IgA Response
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Figure 3. Effect of anti-activin A 
Ab on IgA secretion by B 
lymphoma cells. B lymphoma 
cells were stimulated with LPS 
(12.5μg/ml) and activin A (10 
ng/ml). Titrated anti-activin A Ab 
and anti-TGF-β Ab were pre-incu-
bated for 1 h at room temperature
before addition to culture. Super-
natants were harvested after 3 
days of culture. IgA secretion was 
determined by ELISA. Data are 
means of triplicate cultures±SEM.
Figure 4. Effect of anti-activin A 
Ab on Ig secretion by normal 
spleen B cells. Mouse spleen B 
cells were stimulated with LPS 
(12.5 g/ml) and activin A (10 
ng/ml). As in Fig. 3, anti-activin A
Ab (0.5μg /ml) and anti-TGF-β
Ab (5μg/ml) were added to 
cultures. Supernatants were harve-
sted after 7 days of culture. 
Secretion of Ig isotypes was 
determined by ELISA. Data are 
means of triplicate cultures±SEM.
unclear at the moment. In this regard, we have demonstrated 
in the earlier study that anti-proliferative activity of TGF-β fa-
cilitates IgA CSR leading to an increase of IgA production (18). 
Therein,  we  first  examined  the  effect  of  activin  A  on  the 
growth  of  murine  spleen  B  cells.  LPS  is  generally  adopted 
for the non-specific stimulation of mouse B cells. As shown 
in Fig. 1, LPS increased cell viability up to 4 day of culture. 
Effect of Activin A on the cell viability was marginal while 
TGF-β1  substantially  inhibited  it.  Subsequently,  we  tested 
the effect of activin A on B cell proliferation. In parallel to Characterization of Activin A-induced IgA Response
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Figure 5. Activin A increases IgA secretion by mesenteric lymph node cells. Mesenteric lymph node (1×10
6) cells were treated 10 ng/ml of
activin A, and 0.2 ng/ml of TGF-β1. Supernatants were harvested after 7 days of culture. IgA, IgG1, and IgG2b secretion was determined by 
ELISA. Data are means of triplicate cultures±SEM.
cell viability, Activin A had no influence on cell proliferation 
though anti-proliferative activity of TGF-β1 was evident (Fig. 
2).  These  results  suggest  that  activin  A  increases  IgA  ex-
pression through the mechanism different from that of TGF-
β1 and that activin A has such activity without inhibiting cell 
proliferation. 
Activin A specifically enhances IgA expression inde-
pendent of the activity of TGF-β1 
T h e n ,  h o w  d o e s  a c t i v i n  A  s t i m u l a t e  B  c e l l s  t o  e x p r e s s  I g A 
isotype expression? To assess its underlying mechanism, we 
examined the possible involvement of TGF-β in the activin 
A-induced IgA secretion. In the culture of CH12F3-2A B cell 
lymphoma, the activin A-induced IgA production was abro-
gated by anti-activin A Ab in a dose dependent manner (Fig. 
3).  In  contrast,  anti-TGFβ1  A b  f a i l e d  t o  e l i m i n a t e  t h e  I g A  
response enhanced by activin A. Moreover, in normal spleen 
B  cell  cultures,  a  similar  pattern  of  IgA  secretion  was  ob-
served  when  anti-activin  A  Ab  and  anti-TGFβ1  Ab  were 
treated as shown in Fig. 4. On the other hand, anti-activin 
A Ab or anti-TGFβ1 Ab little affected secretion patterns of 
IgM, IgG2b, and IgG3. These results indicate that activin A 
selectively induces IgA expression and that this activity of ac-
tivin A is independent of that of TGF-β1. Furthermore, these 
results exclude the possibility that activin A has such activity 
through  induction  of  TGF-β1  production. 
Effect of activin A on IgA secretion by mesenteric 
lymph node B cells
Peyer’s patch (PP) is the most important gut-associated lym-
phoid tissue, where most of IgA B cells are committed (19). 
Therein, it is difficult to isolate surface IgA negative B cells 
from PP. On the other hand, mesenteric lymph node (MLN) 
B cells are also known to be the site for IgA B cell commit-
ment  (20,21).  Here,  we  were  interested  if  activin  A  affects 
IgA production by MLN B cells. As shown in Fig. 5, activin 
A, as similar to TGF-β1, increased IgA secretion by MLN cells 
but  neither  IgG1  nor  IgG2b. 
    In summary, we demonstrate in this study that activin A, 
as  similar  to  TGF-β1,  selectively  increases  IgA  expression. 
Nevertheless, Activin A had no influence on cell proliferation, 
which is in contrast to the anti-proliferative property of TGF-
β1.  We  have  recently  shown  that  activin  A,  like  TGF-β1 
adopts  Smad3  and  Smad4  as  the  main  signaling  mediators 
(15). Therefore, it still remains to determine the mechanism 
by which activin A causes IgA isotype switching, distinguish-
ing  from  that  of  TGF-β1.  Finally  we  observed  that  activin 
A can stimulate mesenteric lymph node B cells to produce 
IgA. These results raise the possibility that activin A may have 
i m p o r t a n t  e f f e c t s  o n  t h e  e x p r e s s i o n  o f  I g A  i n  t h e  g u t .
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